These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37980109)
21. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Carmosino MJ; Brousseau KM; Arciniegas DB; Corboy JR Arch Neurol; 2005 Apr; 62(4):585-90. PubMed ID: 15824257 [TBL] [Abstract][Full Text] [Related]
23. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Clarke MA; Samaraweera AP; Falah Y; Pitiot A; Allen CM; Dineen RA; Tench CR; Morgan PS; Evangelou N Mult Scler; 2020 Apr; 26(4):433-441. PubMed ID: 31668125 [TBL] [Abstract][Full Text] [Related]
24. "Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Solomon AJ; Klein EP; Bourdette D Neurology; 2012 Jun; 78(24):1986-91. PubMed ID: 22581930 [TBL] [Abstract][Full Text] [Related]
34. Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors. Carnero Contentti E; López PA; Criniti J; Alonso R; Silva B; Luetic G; Correa-Díaz EP; Galleguillos L; Navas C; Soto de Castillo I; Hamuy FDB; Gracia F; Tkachuk V; Weinshenker BG; Rojas JI Mult Scler; 2023 Feb; 29(2):277-286. PubMed ID: 36453614 [TBL] [Abstract][Full Text] [Related]
35. CADASIL and multiple sclerosis: A case report of prolonged misdiagnosis. Carone DA Appl Neuropsychol Adult; 2017; 24(3):294-297. PubMed ID: 27712110 [TBL] [Abstract][Full Text] [Related]
36. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Selchen D; Bhan V; Blevins G; Devonshire V; Duquette P; Grand'Maison F; Kremenchutzky M; Lapierre Y; Li D; von Riedemann SJ; Freedman M Neurology; 2012 Dec; 79(23 Suppl 2):S1-15. PubMed ID: 23212280 [TBL] [Abstract][Full Text] [Related]
37. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial. Ontaneda D; Sati P; Raza P; Kilbane M; Gombos E; Alvarez E; Azevedo C; Calabresi P; Cohen JA; Freeman L; Henry RG; Longbrake EE; Mitra N; Illenberger N; Schindler M; Moreno-Dominguez D; Ramos M; Mowry E; Oh J; Rodrigues P; Chahin S; Kaisey M; Waubant E; Cutter G; Shinohara R; Reich DS; Solomon A; Sicotte NL; Neuroimage Clin; 2021; 32():102834. PubMed ID: 34592690 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of multiple sclerosis diagnostic criteria in Suzhou, China--risk of under-diagnosis in a low prevalence area. Cheng XJ; Cheng Q; Xu LZ; Zhao HQ; Zhao Z; Wang W; Jiang GX; Fredrikson S Acta Neurol Scand; 2010 Jan; 121(1):24-9. PubMed ID: 19804479 [TBL] [Abstract][Full Text] [Related]
39. Disclosing a misdiagnosis of multiple sclerosis: do no harm? Solomon AJ; Klein E Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):1087-91. PubMed ID: 23917103 [TBL] [Abstract][Full Text] [Related]
40. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Dalton CM; Brex PA; Miszkiel KA; Hickman SJ; MacManus DG; Plant GT; Thompson AJ; Miller DH Ann Neurol; 2002 Jul; 52(1):47-53. PubMed ID: 12112046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]